RELX PLC (NYSE:RELX) Position Increased by Connor Clark & Lunn Investment Management Ltd.

Key Points

• Connor Clark & Lunn Investment Management Ltd. increased its holdings in Relx Plc by 103.4% during the first quarter, now owning 444,360 shares valued at $22.4 million.
• Relx recently declared a semi-annual dividend of $0.2634 per share, with an upcoming payment date of September 16, reflecting a yield of 170%.
• Equity analysts are optimistic about Relx Plc, with a consensus rating of "Buy" and multiple firms raising their target ratings for the stock.

Connor Clark & Lunn Investment Management Ltd. lifted its stake in RELX PLC (NYSE:RELX - Free Report) by 103.4% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 444,360 shares of the technology company's stock after buying an additional 225,947 shares during the period. Connor Clark & Lunn Investment Management Ltd.'s holdings in RELX were worth $22,400,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently modified their holdings of RELX. ABC Arbitrage SA increased its holdings in RELX by 40.1% during the 1st quarter. ABC Arbitrage SA now owns 194,197 shares of the technology company's stock worth $9,789,000 after purchasing an additional 55,579 shares during the last quarter. Massachusetts Financial Services Co. MA boosted its stake in shares of RELX by 103.7% during the 1st quarter. Massachusetts Financial Services Co. MA now owns 106,220 shares of the technology company's stock valued at $5,355,000 after buying an additional 54,062 shares during the last quarter. Cambridge Investment Research Advisors Inc. boosted its stake in shares of RELX by 19.5% during the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 18,957 shares of the technology company's stock valued at $956,000 after buying an additional 3,092 shares during the last quarter. LPL Financial LLC boosted its stake in shares of RELX by 9.5% during the 1st quarter. LPL Financial LLC now owns 252,566 shares of the technology company's stock valued at $12,732,000 after buying an additional 21,977 shares during the last quarter. Finally, Merit Financial Group LLC boosted its stake in shares of RELX by 77.7% during the 1st quarter. Merit Financial Group LLC now owns 11,757 shares of the technology company's stock valued at $593,000 after buying an additional 5,139 shares during the last quarter. Hedge funds and other institutional investors own 15.02% of the company's stock.

RELX Stock Performance

RELX stock traded down $0.11 during mid-day trading on Thursday, reaching $47.67. The company's stock had a trading volume of 1,213,081 shares, compared to its average volume of 1,366,513. The company has a current ratio of 0.47, a quick ratio of 0.42 and a debt-to-equity ratio of 2.55. RELX PLC has a twelve month low of $44.19 and a twelve month high of $56.33. The business has a 50 day moving average price of $52.29 and a 200-day moving average price of $51.55. The firm has a market cap of $87.44 billion, a price-to-earnings ratio of 25.63, a PEG ratio of 3.12 and a beta of 0.88.

RELX Cuts Dividend

The firm also recently disclosed a semi-annual dividend, which will be paid on Tuesday, September 16th. Investors of record on Friday, August 8th will be paid a dividend of $0.2634 per share. The ex-dividend date is Friday, August 8th. This represents a yield of 170.0%. RELX's dividend payout ratio is 28.49%.

Wall Street Analyst Weigh In

RELX has been the subject of several research analyst reports. Wall Street Zen upgraded RELX from a "hold" rating to a "buy" rating in a research note on Saturday, July 26th. Morgan Stanley reiterated an "overweight" rating on shares of RELX in a research note on Wednesday, April 16th. Five analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Buy".

About RELX

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.